Emerald Clinical Trials Appoints Glenn Kerkhof as Interim CEO Following Leadership Transition
核心洞察
Emerald Clinical Trials (搜索) announced the immediate departure of CEO Mary Gunn and appointed Glenn Kerkhof as Interim CEO to ensure operational continuity.
Kerkhof brings over 30 years of clinical research experience, having previously served as CEO of Chiltern (搜索) and Executive Chairman of George Clinical (搜索).
The global CRO serves over 100 biotechnology companies and 6 of the top 10 pharmaceutical companies while conducting a formal search for a permanent CEO.
Emerald Clinical Trials (搜索), a leading global clinical research organization, announced a significant leadership transition with the immediate departure of CEO Mary Gunn and the appointment of Glenn Kerkhof as Interim CEO. The Board of Directors has initiated a formal search for a permanent chief executive while ensuring operational continuity during the transition period.
Leadership Transition Details
The Board appointed Kerkhof, a long-standing Board member and experienced CRO executive, to lead the organization through this transitional phase. Sean Carney, Chair of the Board, expressed confidence in the interim leadership arrangement, stating, "Emerald Clinical Trials (搜索) is a leading CRO with global capabilities and with Glenn stepping in as Interim CEO, we are confident in our ability to maintain momentum and deliver for our clients."
Executive Experience and Background
Kerkhof brings more than 30 years of executive experience in clinical research and pharmaceutical services to his interim role. His previous leadership positions include serving as CEO of Chiltern (搜索), where he led the company through major international expansion. Additionally, he served as Executive Chairman of George Clinical (搜索), which later became Emerald Clinical Trials (搜索), helping shape its growth across Asia.
"Emerald Clinical's strengths lie in our therapeutic focus, scientific depth and close client partnerships," Kerkhof said. "I am focused on a smooth transition, strong delivery for customers, and supporting our global teams. I am committed to building on our momentum and leading with clarity and purpose."
Company Profile and Market Position
Emerald Clinical Trials (搜索) operates as a global clinical research organization serving over 100 biotechnology companies and 6 of the top 10 pharmaceutical companies. Headquartered in Singapore, the company provides comprehensive clinical trial services to clients globally, offering solutions across all trial phases. The organization is driven by operational expertise and scientific excellence in delivering clinical research services worldwide.